Human Herpesvirus 6 Encephalitis Following Axicabtagene Ciloleucel Treatment for Refractory Diffuse Large B Cell Lymphoma
Mili Shah(King's College Hospital), Robin Sanderson(King's College Hospital NHS Foundation Trust), Catherine Hockings(King's College Hospital), Victoria Potter(King's College Hospital NHS Foundation Trust), Victoria Metaxa(Apple (Israel)), Piers Patten, Kirsty Cuthill, Andrea Kühnl(King's College Hospital), Reuben Benjamin(King's College London), Shu Ping Wong(Ministry of Health), Antonio Pagliuca, Malur Sudhanva(King's College Hospital), Orla Stewart, Shafqat Inam(The Alfred Hospital), Deborah Yallop(King's College Hospital NHS Foundation Trust), Gregory Shields(King's College Hospital)
Cited by 20
Related Papers
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
|The Lancet Oncology|2021|614
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2016|538
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
|The Lancet|2020|366
Diagnosis of severe respiratory infections in immunocompromised patients
|Intensive Care Medicine|2020|340